18.08
+0.16(+0.89%)
Currency In USD
| Previous Close | 17.92 |
| Open | 17.99 |
| Day High | 18.32 |
| Day Low | 17.91 |
| 52-Week High | 19.06 |
| 52-Week Low | 5.55 |
| Volume | 359,087 |
| Average Volume | 429,936 |
| Market Cap | 795.67M |
| PE | -54.79 |
| EPS | -0.33 |
| Moving Average 50 Days | 15.96 |
| Moving Average 200 Days | 11.62 |
| Change | 0.16 |
If you invested $1000 in AxoGen, Inc. (AXGN) 10 years ago, it would be worth $5,721.52 as of February 05, 2025 at a share price of $18.08. Whereas If you bought $1000 worth of AxoGen, Inc. (AXGN) shares 5 years ago, it would be worth $1,287.75 as of February 05, 2025 at a share price of $18.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Feb 03, 2025 1:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jesse Bishop a
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jan 10, 2025 10:00 PM GMT
Craig Swandal, experienced medical device manufacturing executive, joins leadership teamALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical so
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
GlobeNewswire Inc.
Jan 10, 2025 1:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quar